Elif Yilmaz, MD

Department of Internal Medicine at UT Southwestern Medical Center

Published Articles (1)

CAR-T Cell Therapy in Aggressive Lymphoma: Standard-of-Care Products, Sequencing, and Frontline Use

May 12, 2026

Expert commentary on CAR-T cell therapy in aggressive lymphoma, including DLBCL and mantle cell lymphoma, with insights on product selection, toxicity, sequencing strategies, and frontline applications.